Home > Products > Biosimilars

BioSIM anti-Human IL-12 Antibody (Ustekinumab Biosimilar), Research Grade

Catalog: SIM0009
Cost advantage to: SIM0020
Isotype: IgG1-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic Ustekinumab biosimilar (same variable regions, ideal for research) binds human p40 (IL-12β, 40 kDa subunit of IL-12/IL-23). IL-12 (from activated monocytes/macrophages/dendritic cells) aids T lymphocyte differentiation, IFNγ production, NK cell cytotoxicity; IL-23 from dendritic/epithelial cells. C17.8 neutralizes IL-12/IL-23; Ustekinumab treats Crohn’s disease, plaque psoriasis, psoriatic arthritis.
 

Specifications

Product Name BioSIM anti-Human IL-12 Antibody (Ustekinumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG1-kappa
Target IL-12
Other Names CNTO1275, TT-20, BFI-751, AVT04, CAS: 815610-63-0
CAS 815610-63-0
Reactivity Human
Host Species Human
Background This non-therapeutic Ustekinumab biosimilar (same variable regions, ideal for research) binds human p40 (IL-12β, 40 kDa subunit of IL-12/IL-23). IL-12 (from activated monocytes/macrophages/dendritic cells) aids T lymphocyte differentiation, IFNγ production, NK cell cytotoxicity; IL-23 from dendritic/epithelial cells. C17.8 neutralizes IL-12/IL-23; Ustekinumab treats Crohn’s disease, plaque psoriasis, psoriatic arthritis.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products